Pharmaceutical Industry representatives speak out on personalised medicine
11 januari 2018
(bio-)Pharmaceutical industry emphasizes the importance of Personalised Medicine
27 november 2017
About the illusion of evidence-based practice in healthcare
25 juli 2017
RIVM analysis: Personalised medicine in medical practice
26 juni 2017
Focus on Personalised Medicine on the Pivot Park
29 mei 2017
Vitromics participates in the foundation of the Personalised Medicine Knowledge Institute (PMKi).
18 mei 2017
VitrOmics organizes the Personalised Medicine theme on DIA-Europe conference
maandag 03 maart 2014
Personalised medicine is for the first time selected as one of the themes for the European conference of the Drug Information Association which will take place this March the 25th-27th in Vienna. VitrOmics has been invited, as expert in this area, to organize a half day lecture programme. Four session topics have been defined, in collaboration with co-theme leader Dr Anna Bucsics who recently retired from the Main Association of Austrian Social Security Institutions, covering the many facets of personalised medicine. Chairpersons as well as presenters are experts from the personalised medicine field. These sessions offer the opportunity to get up to speed with the current developments in personalised medicine field.
Session 1: translation of personalised medicine concepts, chaired by Dr Michael Zühlsdorf (senior director Oncology, Global Head translational and Biomarker Research, Merck KGaA).
Session 2: from biomarkers to companion diagnostics with Dr Jens Grueger (Head Global Pricing & Market Access, F. Hoffmann-LaRoche, Division Pharma) as chairman.
Session 3: Health economic aspects of personalised medicine with Prof Brian Godman (Karolinska Institute, University of Strathclyde and Oswaldo Cruz Foundation) as chairman
Session 4: Societal perspective on personalised medicine, chaired by Dr Sabine Vogel (Head of the pharma team van de Austrian Health Institute).